Nurse Practitioner, Family · Oklahoma City, OK
NPI
1679942585
Since 2015
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
5600 N May Ave Ste 310
Oklahoma City, OK, 73112
Phone (888) 731-8994
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
2,075 services
Medicare patients, 2024
124
Average age 72
Drug cost, 2024
$570K
5,388 prescriptions
Company payments, 2025
$265
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jayne D Fortenberry was code 99213 (office e&m - established), 321 times for 115 patients. In total Jayne D Fortenberry billed 2,075 services in 67 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 321 | 115 | $49.65 | $16K |
| 80053 Clinical Chemistry | Office | 272 | 107 | $10.35 | $2,815 |
| 81001 Clinical Chemistry | Office | 241 | 101 | $3.11 | $750 |
| 83036 Blood Count | Office | 229 | 86 | $9.52 | $2,180 |
| 85025 Blood Count | Office | 156 | 90 | $7.61 | $1,187 |
| 80061 Clinical Chemistry | Office | 82 | 70 | $13.12 | $1,076 |
| 82044 Clinical Chemistry | Office | 52 | 52 | $6.11 | $318 |
| 99214 Office E&M - Established | Office | 30 | 25 | $78.68 | $2,360 |
| G0008 Administration of influenza virus vaccine | Office | 29 | 29 | $30.07 | $872 |
| 99212 Office E&M - Established | Office | 29 | 25 | $29.14 | $845 |
| 90662 Vaccine Product | Office | 25 | 25 | $81.42 | $2,036 |
| 95251 Test - Miscellaneous | Office | 20 | 13 | $21.97 | $439 |
| 82248 Clinical Chemistry | Office | 16 | 12 | $4.92 | $78.72 |
By year: 2022 $44K for 2,038 services; 2023 $53K for 2,194 services; 2024 $40K for 2,075 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 272 | 107 | $10.35 | $2,815 |
| 81001 Clinical Chemistry | 241 | 101 | $3.11 | $750 |
| 83036 Blood Count | 229 | 86 | $9.52 | $2,180 |
| 85025 Blood Count | 156 | 90 | $7.61 | $1,187 |
| 80061 Clinical Chemistry | 82 | 70 | $13.12 | $1,076 |
| 82044 Clinical Chemistry | 52 | 52 | $6.11 | $318 |
| 82248 Clinical Chemistry | 16 | 12 | $4.92 | $78.72 |
Medicare prescription drug claims, 2024
In 2024, the drug Jayne D Fortenberry prescribed most often to Medicare patients was Jardiance (Empagliflozin), with 255 prescriptions and refills. In total Jayne D Fortenberry wrote 5,388 Medicare prescriptions that cost $570K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | 255 | 255 | 35 | $148K |
| Rosuvastatin Calcium Generic | 223 | 229 | 31 | $904 |
| Ozempic Semaglutide | 221 | 226 | 32 | $218K |
| Losartan Potassium Generic | 206 | 206 | 30 | $925 |
| Atorvastatin Calcium Generic | 198 | 198 | 29 | $741 |
| Amlodipine Besylate Generic | 193 | 193 | 27 | $628 |
| Montelukast Sodium Generic | 159 | 159 | 23 | $612 |
| Lisinopril Generic | 158 | 166 | 25 | $469 |
| Metformin Hcl Er Metformin Hcl | 148 | 148 | 17 | $623 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 136 | 136 | 32 | $3,308 |
| Gabapentin Generic | 133 | 133 | 20 | $1,097 |
| Omeprazole Generic | 130 | 141 | 24 | $1,013 |
| Carvedilol Generic | 119 | 119 | 25 | $507 |
| Synthroid Levothyroxine Sodium | 111 | 111 | 15 | $4,444 |
| Diclofenac Sodium Generic | 109 | 113 | 37 | $748 |
Brand drugs: 1,335 claims; generic drugs: 3,855 claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jayne D Fortenberry $265 ($265 in general payments such as food, travel and fees) from 1 company. The largest payer was Medtronic, Inc. with $265.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 2 | $265 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.